Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma From Patients With Non Small Cell Lung Carcinoma (NSCLC)

NCT02762877 is registered in ClinicalTrials.gov with Genomic Health®, Inc. as lead sponsor.

NCT NCT02762877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02762877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma From Patients With Non Small Cell Lung Carcinoma (NSCLC)
Lead sponsor
Genomic Health®, Inc.
Phase
Observational
Overall status
Terminated
Start date
April 30, 2016
Completion date
June 19, 2019
Enrollment
140 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung carcinoma